Brought to you by 
Second JT / Tularik alliance researches transcription factors
07 May 2002
Executive Summary
Japan Tobacco and Tularik (transcription factors that regulate gene expression) will collaborate for three years on discovery and development of compounds that modulate a class of proteins called orphan nuclear receptors (ONRs).
Deal Industry
- Pharmaceuticals
Deal Status
- Terminated
Deal Type
-
Alliance
- Includes Contract
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Second JT / Tularik alliance researches transcription factors
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice